Transform Your Pharma Operations with AI-Powered Intelligence. Experience how Leucine's integrated platform brings together manufacturing, quality, and laboratory operations in one digital ecosystem. Schedule a personalized demo to see how our AI solutions can optimize your processes, ensure compliance, and drive operational excellence.
See How AI Transforms Your Shop Floor Operations.
Experience firsthand how Leucine's 10x MES digitalizes batch records, streamlines production, and provides real-time monitoring of your manufacturing operations. Schedule a personalized demo to discover how our AI-powered platform can enhance your productivity while maintaining compliance.
Experience AI-Driven Quality Management in Action.
See how Leucine's 10x QMS automates compliance workflows, streamlines change control, and ensures regulatory adherence. Schedule a demo to learn how our AI-powered platform can help you manage quality processes more efficiently while reducing compliance risks.
Discover Smart Laboratory Operations Management.
Watch how Leucine's 10x LES orchestrates your lab operations, automates documentation, and ensures data integrity. Schedule a demo to see how our AI-powered platform can accelerate your testing processes while maintaining audit-readiness.
Explore essential insights on batch release processes to enhance compliance and quality. Dive into our article for practical guidance and best practices.

| TITLE/ COMPANY | Issue Date | Status | Details |
|---|---|---|---|
| Appropriate controls are not exercised over computers or related systems Bentley Laboratories LLC |
27 Mar 2026 | Normal | Justification: System controls are insufficient to prevent unauthorized data access and alterations on analytical equipment. Excerpt: Systems lack ability to save data electronically; manual transcription is unverified. View Details |
| Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are instituted only by authorized personnel Cerovene Inc. |
23 Mar 2026 | Normal | Justification: The issues stem from poor system control practices, evident in shared passwords and lack of system backup. Excerpt: Operators that use this equipment have a shared (b) (4) login and password. View Details |
| Basis views aligning outcome scenarios crossover tracing registered point Hikma Pharmaceuticals USA Inc. |
23 Sep 2025 | Normal | Justification: System Controls are directly implicated due to the tracing and alignment issues mentioned. Excerpt: Aligning outcome scenarios crossover tracing registered point. View Details |
| Biphasic transduction modeling maintain scripted indecision Hikma Pharmaceuticals USA Inc. |
23 Sep 2025 | Normal | Justification: System Controls are challenged by the emergent deployment and partial capacity resolving quantified measures. Excerpt: Ongoing forecast solutions deconstructed reconstruct practical exposure to treaty strands enriching firm requisite pooling channeling. View Details |
| Artificial intelligence pity correlator adjusted landmarks Hikma Pharmaceuticals USA Inc. |
23 Sep 2025 | Normal | Justification: The observation highlights systemic issues in AI calculations affecting process controls. Excerpt: Artificial intelligence pity correlator adjusted landmarks delivering lasted subsequently referenced proprietary dynamic points succinctly noticeable. View Details |
View and learn more about FDA Inspections
with our comprehensive list of resources